Enjuvia FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 10, 2004)
Brand name: Enjuvia
Generic name: synthetic conjugated estrogens, B
Dosage form: Tablets
Company: Duramed Pharmaceuticals
Treatment for: Postmenopausal Symptoms, Atrophic Vaginitis
Marketing Status: Discontinued
Enjuvia (synthetic conjugated estrogens, B) is a synthetic conjugated estrogen product indicated for the treatment of menopausal vasomotor symptoms and for the treatment of vaginal dryness and atrophy.
Development Timeline for Enjuvia
|Apr 30, 2007||Duramed's Enjuvia (Synthetic Conjugated Estrogens, B) TabletsReceives Two New FDA Approvals|
|May 10, 2004||Enjuvia Duramed Pharmaceuticals - Treatment for Menopausal Vasomotor Symptoms|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.